Phase 2 Viral reactivation Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Third Party Viral Specific T-cells (VSTs)
Viral reactivationViral InfectionInfection in an Immunocompromised Host
Children's Hospital Medical Center, Cincinnati750 enrolled4 locationsNCT02532452
Recruiting
Phase 1Phase 2
Donor-Derived Viral Specific T-cells (VSTs)
Viral reactivationallogeneic stem cell transplantViral Infection
Children's Hospital Medical Center, Cincinnati750 enrolled3 locationsNCT02048332
Recruiting
Phase 2
Phase I/II clinical trial to assess the safety and biological efficacy of treatment with virus-specific, cytotoxic T-lymphocytes from partially matched third-party unrelated donors, in stem cell transplant patients with viral reactivation unresponsive to standard therapy (R3ACT trial)
Viral reactivation post-allogeneic stem cell transplant
Western Sydney Local Health Districit30 enrolled15 locationsACTRN12613000603718